- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/58 - Radicals substituted by nitrogen atoms
Patent holdings for IPC class C07D 333/58
Total number of patents in this class: 135
10-year publication summary
|
7
|
4
|
6
|
7
|
9
|
6
|
7
|
8
|
4
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Idemitsu Kosan Co., Ltd. | 4223 |
7 |
| Neoculi Pty Ltd | 18 |
7 |
| Janssen Pharmaceutica N.V. | 3369 |
6 |
| Bayer Pharma AG | 1054 |
5 |
| Connexios Life Sciences Pvt. Ltd. | 12 |
4 |
| Escient Pharmaceuticals, Inc. | 42 |
4 |
| Tactogen Inc | 37 |
3 |
| LG Chem, Ltd. | 17644 |
2 |
| The Regents of the University of California | 20059 |
2 |
| Syngenta Participations AG | 1847 |
2 |
| Takeda Pharmaceutical Company Limited | 2705 |
2 |
| 4SC AG | 77 |
2 |
| Friedrich-Alexander-Universitaet Erlangen-Nuernberg | 110 |
2 |
| Nippon Chemiphar Co., Ltd. | 227 |
2 |
| PRISM BioLab Co., Ltd. | 19 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 833 |
2 |
| The University of North Carolina at Chapel Hill | 2052 |
2 |
| Janssen Biopharma, Inc. | 40 |
2 |
| Enyo Pharma | 55 |
2 |
| Recludix Pharma, Inc. | 12 |
2 |
| Other owners | 73 |